Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...

Welsbach Technology Metals Acquisition Corp. Announces Extension to Business Combination Deadline New York, NY, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Welsbach Technology Metals Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange,...

Welsbach Technology Metals Acquisition Corp. Announces Extension to Business Combination Deadline New York, NY, April 28, 2023 (GLOBE NEWSWIRE) -- Welsbach Technology Metals Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange,...

ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc. YONKERS, N.Y., May 26, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the...

Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale VICTORIA, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”)...